Axogen, Inc. (Nasdaq: AXGN) has completed its acquisition of privately held BioCircuit Technologies, Inc., gaining ownership of NerveTape™, a device ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE